Abstract
An environmentally benign catalytic method for efficient synthesis of quinoxaline derivatives via the condensation reaction of 1,2-diamines and 1,2-dicarbonyl compounds using ZrOCl2.8H2O in EtOH as a standard green solvent under mild conditions has been developed. The reusability of the catalyst has been successfully examined without any noticeable loss of its catalytic activity.
Keywords: Quinoxaline, 1,2-diamines, 1,2-dicarbonyl compounds, ZrOCl2.8H2O, ethanol, EtOH, DPPZ, DPQ, DFQ, MnO2
Letters in Organic Chemistry
Title: A New Catalytic Method for Eco-Friendly Synthesis of Quinoxalines by Zirconium (IV) Oxide Chloride Octahydrate Under Mild Conditions
Volume: 8 Issue: 3
Author(s): Maasoumeh Jafarpour, Abdolreza Rezaeifard and Mahdieh Heidari
Affiliation:
Keywords: Quinoxaline, 1,2-diamines, 1,2-dicarbonyl compounds, ZrOCl2.8H2O, ethanol, EtOH, DPPZ, DPQ, DFQ, MnO2
Abstract: An environmentally benign catalytic method for efficient synthesis of quinoxaline derivatives via the condensation reaction of 1,2-diamines and 1,2-dicarbonyl compounds using ZrOCl2.8H2O in EtOH as a standard green solvent under mild conditions has been developed. The reusability of the catalyst has been successfully examined without any noticeable loss of its catalytic activity.
Export Options
About this article
Cite this article as:
Jafarpour Maasoumeh, Rezaeifard Abdolreza and Heidari Mahdieh, A New Catalytic Method for Eco-Friendly Synthesis of Quinoxalines by Zirconium (IV) Oxide Chloride Octahydrate Under Mild Conditions, Letters in Organic Chemistry 2011; 8 (3) . https://dx.doi.org/10.2174/157017811795038412
DOI https://dx.doi.org/10.2174/157017811795038412 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Mechanisms in Rheumatic Diseases: Rationale for Novel Drug Development – Introduction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Use of Propolis in Micro/Nanostructured Pharmaceutical Formulations
Recent Patents on Drug Delivery & Formulation Anti-Inflammatory Activity of Polysaccharide Fraction of Curcuma longa Extract (NR-INF-02)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Combination Antifungal Therapy for Invasive Aspergillosis: Utilizing New Targeting Strategies
Current Drug Targets - Infectious Disorders Peptide Nucleic Acids (PNAs) as Diagnostic Devices for Genetic and Cytogenetic Analysis
Current Pharmaceutical Design Characterization of pDNA-TMC Nanoparticle Interaction and Stability
Current Drug Delivery Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT)
Current Drug Therapy Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews Enhancement of Immunoprotective Effect of CpG-ODN by Formulation with Polyphosphazenes Against E. coli Septicemia in Neonatal Chickens
Current Drug Delivery Intraocular Immune Mechanisms in Uveitis
Current Immunology Reviews (Discontinued) Synthesis and Anti-tubercular Activity of 6-(<i>4</i>-Chloro/Methyl-phenyl)-4- Arylidene-4,5-dihydropyridazin-3(2<i>H</i>)-one Derivatives Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Use of Peptide Libraries for Identification and Optimization of Novel Antimicrobial Peptides
Current Topics in Medicinal Chemistry Immunoadjunctive Therapy against Bacterial Infections Using Herbal Medicines Based on Th17 Cell-mediated Protective Immunity
Current Pharmaceutical Design Synthesis, Anticonvulsant and Antimicrobial Activities of Some New [1-(2-Naphthyl)-2-(pyrazol-1-yl)ethanone]oxime Ethers
Medicinal Chemistry Simultaneously Determining Seven Second-Line Anti-TB Drugs by UHPLC- MS: Application for TDM in HIV-TB Patients
Current Pharmaceutical Analysis <i>In Silico</i> Prediction of Epitopes in Virulence Proteins of Mycobacterium ulcerans for Vaccine Designing
Current Genomics Adjunctive Immunotherapy of Mycobacterial Infections
Current Pharmaceutical Design DD-Ligases as a Potential Target for Antibiotics: Past, Present and Future
Current Medicinal Chemistry Novel Drug Delivery Magnetite Nano-systems Used in Antimicrobial Therapy
Current Organic Chemistry Meet Our Editorial Board Member
Current Medicinal Chemistry